Access Bio Supplies ₩5B Worth of Flu and COVID Self-Test Kits to P&G Affiliate in US
Predicted impact: Medium
₩5B kit supply deal is about 31% of revenue, but repeats a contract already reported in the last 14 days.
950130 · KOSDAQ · ₩950130 · 엑세스바이오
Predicted impact: Medium
₩5B kit supply deal is about 31% of revenue, but repeats a contract already reported in the last 14 days.
Predicted impact: Medium
Contract worth ₩5B, about 31% of last year's revenue of ₩16.2B.
Also known as: Access Bio / 엑세스바이오 / 950130 / KRX:950130
Source: KRX statistical information